Monte M. Winslow
Affiliations: | Stanford University, Palo Alto, CA |
Area:
GeneticsGoogle:
"Monte Winslow"Mean distance: 17.58
Parents
Sign in to add mentor| Gerald Crabtree | grad student | 2006 | Stanford | |
| (Calcineurin/NFAT signaling controls B lymphocyte responses and regulates bone mass.) | ||||
Children
Sign in to add trainee| Christopher D. McFarland | post-doc | 2014-2018 | Stanford (Chemistry Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Blair LM, Juan JM, Sebastian L, et al. (2023) Oncogenic context shapes the fitness landscape of tumor suppression. Nature Communications. 14: 6422 |
| Yousefi M, Andrejka L, Szamecz M, et al. (2023) Fully accessible fitness landscape of oncogene-negative lung adenocarcinoma. Proceedings of the National Academy of Sciences of the United States of America. 120: e2303224120 |
| Gonzalez MA, Lu DR, Yousefi M, et al. (2023) Phagocytosis increases an oxidative metabolic and immune suppressive signature in tumor macrophages. The Journal of Experimental Medicine. 220 |
| Yousefi M, Andrejka L, Winslow MM, et al. (2023) Fully accessible fitness landscape of oncogene-negative lung adenocarcinoma. Biorxiv : the Preprint Server For Biology |
| Lee MC, Cai H, Murray CW, et al. (2023) A multiplexed in vivo approach to identify driver genes in small cell lung cancer. Cell Reports. 42: 111990 |
| Tang R, Shuldiner EG, Kelly M, et al. (2023) Multiplexed screens identify RAS paralogues HRAS and NRAS as suppressors of KRAS-driven lung cancer growth. Nature Cell Biology |
| Yousefi M, Boross G, Weiss C, et al. (2022) Combinatorial Inactivation of Tumor Suppressors Efficiently Initiates Lung Adenocarcinoma with Therapeutic Vulnerabilities. Cancer Research. 82: 1589-1602 |
| Foggetti G, Li C, Cai H, et al. (2022) Tumor suppressor pathways shape EGFR-driven lung tumor progression and response to treatment. Molecular & Cellular Oncology. 9: 1994328 |
| Murray CW, Brady JJ, Han M, et al. (2022) LKB1 drives stasis and C/EBP-mediated reprogramming to an alveolar type II fate in lung cancer. Nature Communications. 13: 1090 |
| Dorsch M, Kowalczyk M, Planque M, et al. (2021) Statins affect cancer cell plasticity with distinct consequences for tumor progression and metastasis. Cell Reports. 37: 110056 |